Companies: 10,795·Total market cap: $144.5T
DexCom, Inc.

DexCom, Inc.

DXCMNASDAQHealthcare● Active
$72.86
+$0.27(+0.37%)
Market Cap$28.1B
P/E Ratio
52W High$89.98
52W Low$54.11
Overview

DexCom, Inc. (DXCM) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

dxcm · stock forecast · 52 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 52 Wall Street analysts in the past 3 months

SellBuy

Buy

52 analysts

consensus

Rating Breakdown

Strong Buy
1
Buy
41
Hold
8
Sell
2
Strong Sell
0
Total: 52 · Buy rate: 80.8%

12-Month Price Target

High

$92.00

Consensus

$80.13

+10.0% upside

Low

$64.00

Median: $80.5 · Last Close: $72.86

The DexCom, Inc. (DXCM) analyst consensus is Buy, based on ratings from 52 Wall Street analysts over the past 3 months. The average 12-month DXCM price target is $80.13, representing +10.0% upside from the current price of $72.86.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $80 (10.0%)

Consensus Target

$80.13

10.0% upside

High Target

$92

26.3%

Low Target

$64

-12.2%

Current Price

$72.86

as of today

Based on analyst price targets, the DXCM stock price prediction for the next 12 months ranges from $64 to $92. The consensus DXCM price forecast of $80.13 implies 10.0% upside from the current price of $72.86.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$76.505.00%

1-day model range: $76.1–$76.9. Peak: $76.9 (+5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$73-0.4%
2028$72-0.7%
2029$72-0.9%
2030$72-1.0%
2031-1.0%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

86%0%14%
12Buy
0Neutral
2Sell
RSI (14)78.8Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · DXCM · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$73.31SELL
MA 10$72.70BUY
MA 20$68.07BUY
MA 50$64.57BUY
MA 100$67.42BUY
MA 200$67.65BUY
Current $DXCM · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$72.85BUY
EMA 10$71.87BUY
EMA 20$69.41BUY
EMA 50$66.85BUY
EMA 100$66.90BUY
EMA 200$69.05BUY
Current $DXCM · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Stifel2026-06-05
Maintains
BuyBuy
Citigroup2026-05-28
Maintains
BuyBuy
B of A Securities2026-05-18
Maintains
BuyBuy
Canaccord Genuity2026-05-18
Maintains
BuyBuy
Barclays2026-05-18
Maintains
UnderweightUnderweight
Citigroup2026-05-04
Maintains
BuyBuy
TD Cowen2026-05-01
Maintains
BuyBuy
Barclays2026-05-01
Maintains
UnderweightUnderweight
Canaccord Genuity2026-05-01
Maintains
BuyBuy
Citigroup2026-03-11
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on DexCom, Inc. (DXCM) stock. Of the recent 326 rating actions, 28 were upgrades and 22 were downgrades. 52 analysts currently cover DXCM.

Analyst Recommendation Trends

Buy ratings312
Hold ratings00
Sell ratings00

DXCM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$5.2B

↓ 19.7% YoY

Revenue Next Year

$5.8B

↑ 11.5% YoY

EPS This Year

$2.59

EPS Next Year

$3.08

↑ 18.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast DXCM EPS of $2.59 for the current fiscal year, based on estimates from 14 analysts. The DXCM revenue forecast is $5.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The DXCM stock forecast is supported by two independent data sources: analyst consensus ratings from 52 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DXCM price target is $80.13 (+10.0% upside), with an analyst consensus of Buy.

The DXCM short-term stock prediction for tomorrow is $76.50 (+5.00%). The DXCM stock price prediction for 2027 estimates an average of $73. The DXCM stock prediction for 2030 projects a range of $68–$76.

DexCom, Inc. trades on NASDAQ under the ticker DXCM. The DXCM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 81% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

DXCM forecast · 8 questions

According to 52 Wall Street analysts, the average 12-month DXCM price target is $80.13, with a high forecast of $92.00 and a low of $64.00. The median price target is shown in the chart above when available. This implies +10.0% potential upside from the current price of $72.86.

DXCM price targetWhat is DXCM price targetDXCM analyst price targetDXCM 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.